LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi AB (STO:PROB) today announces a four-year collaborative research agreement with Professor Michiel Kleerebezem at the Host Microbe Interactomics Group at Wageningen University. The aim of the collaboration is to clarify mechanisms of action for anti-inflammatory activity of probiotic bacteria in order to enable a continued development of novel effective probiotic products.
Help employers find you! Check out all the jobs and post your resume.
